- Home
- CASI vs LGL Comparison
CASI vs LGL Comparison
Compare CASI & LGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CASI
- LGL
- Stock Information
- Founded
- CASI 1991
- LGL 1917
- Country
- CASI China
- LGL United States
- Employees
- CASI N/A
- LGL N/A
- Industry
- CASI Biotechnology: Pharmaceutical Preparations
- LGL Industrial Machinery/Components
- Sector
- CASI Health Care
- LGL Technology
- Exchange
- CASI Nasdaq
- LGL Nasdaq
- Market Cap
- CASI 31.0M
- LGL 34.0M
- IPO Year
- CASI 1996
- LGL N/A
- Fundamental
- Price
- CASI $1.89
- LGL $6.12
- Analyst Decision
- CASI Strong Buy
- LGL
- Analyst Count
- CASI 1
- LGL 0
- Target Price
- CASI $4.00
- LGL N/A
- AVG Volume (30 Days)
- CASI 8.4K
- LGL 4.3K
- Earning Date
- CASI 05-20-2025
- LGL 05-23-2025
- Dividend Yield
- CASI N/A
- LGL N/A
- EPS Growth
- CASI N/A
- LGL 59.20
- EPS
- CASI N/A
- LGL 0.08
- Revenue
- CASI $28,537,000.00
- LGL $4,292,000.00
- Revenue This Year
- CASI N/A
- LGL N/A
- Revenue Next Year
- CASI N/A
- LGL N/A
- P/E Ratio
- CASI N/A
- LGL $84.00
- Revenue Growth
- CASI N/A
- LGL 16.69
- 52 Week Low
- CASI $1.64
- LGL $4.86
- 52 Week High
- CASI $7.67
- LGL $7.28
- Technical
- Relative Strength Index (RSI)
- CASI 44.54
- LGL 37.74
- Support Level
- CASI $1.64
- LGL $6.85
- Resistance Level
- CASI $1.94
- LGL $7.08
- Average True Range (ATR)
- CASI 0.09
- LGL 0.16
- MACD
- CASI -0.00
- LGL -0.05
- Stochastic Oscillator
- CASI 55.77
- LGL 0.00
About CASI CASI Pharmaceuticals Inc.
CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.
About LGL LGL Group Inc. (The)
LGL Group Inc is a holding company engaged in services, merchant investment and manufacturing business activities. The company has two reportable segments; Electronic Instruments and Merchant Investment. The Electronic Instruments segment, which generates key revenue, is focused on designing and manufacturing high-performance Frequency and Time reference standards that form the basis for timing and synchronization in various applications including satellite communication, time transfer systems, network synchronization, electricity distribution, and metrology. The Merchant Investment segment comprises various investment vehicles in which the company invests its capital.